Trulicity

ACT EU multi-stakeholder platform annual meeting, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 29 October 2025, 09:30 (CET) to 29 October 2025, 17:00 (CET)

Human medicines European public assessment report (EPAR): Inflectra, infliximab, Date of authorisation: 10/09/2013, Revision: 34, Status: Authorised

Scientific advice and protocol assistance adopted during the CHMP meeting 26-29 January 2026

Human medicines European public assessment report (EPAR): Uplizna, inebilizumab, Date of authorisation: 25/04/2022, Revision: 9, Status: Authorised

Human medicines European public assessment report (EPAR): Bronchitol, mannitol, Date of authorisation: 13/04/2012, Revision: 20, Status: Authorised

Human medicines European public assessment report (EPAR): Trecondi, treosulfan, Date of authorisation: 20/06/2019, Revision: 6, Status: Authorised

Human medicines European public assessment report (EPAR): Imbruvica, ibrutinib, Date of authorisation: 21/10/2014, Revision: 37, Status: Authorised

Immune and Inflammatory Diseases Working Party (IIWP)

Agenda - Medicine Shortages SPOC Working Party meeting 17 February 2026